ON Semiconductor vs Revvity Inc — how do they compare? ON Semiconductor trades at $70.75 (market cap $27.67B), while Revvity Inc trades at $124.14 (market cap $14.18B). The key difference: ON Semiconductor is the larger of the two by market cap, and Revvity Inc pays a 0.22% dividend while ON Semiconductor pays none. Which is the better fit depends on your goals.
| ON | RVTY | |
|---|---|---|
Market Cap | $27.67B | $14.18B |
Sector | Technology | Technology |
52-Week High | $133.93 | $130.94 |
52-Week Low | $44.90 | $82.26 |
Enterprise Value | $28.29B | $16.50B |
Dividend Yield | — | 0.22% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
RVTY trades at $127.08, down 2.41% on the day, with a bullish technical signal from moving averages and strong support at $126. The company reported Q2 2026 EPS of $1.41, beating estimates, and raised its full-year outlook, driven by diagnostics strength and improved cash flow. Recent news includes the acquisition of Human Cell Design and the launch of the SuperFlex prenatal screening system.
Outlook is positive with 52% analyst buy ratings and a $135.25 consensus price target, implying ~6% upside. Risks include a premium valuation (P/E 61.1) and execution of growth initiatives. Strong institutional interest, such as Bank of New York Mellon's $78.77 million investment, supports confidence in the stock's trajectory.
Trailing returns across standard periods
Latest headlines on both assets
Onsemi develops power and sensing semiconductors for automotive, industrial, and energy applications. Its products support functions such as electric vehicle systems, energy conversion, automation, and intelligent sensing.
Read more on ON →Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →